Yang Zhuoxuan, Wang Tianjie, Dong Ying, Liu Long, Xue Xuan, Wu Jine, Hao Liuyi, Yuan Jiansong, Cui Jingang, Qiao Shubin, Yang Weixian
Department of Cardiology, Yuncheng Central Hospital of Shanxi Province, 044000 Yuncheng, Shanxi, China.
Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, 100037 Beijing, China.
Rev Cardiovasc Med. 2023 May 18;24(5):146. doi: 10.31083/j.rcm2405146. eCollection 2023 May.
To investigate the risk factors for myocardial infarction, recurrent in-stent restenosis (ISR) and target vessel revascularization (TVR) in patients with coronary ISR within 4 years after revascularization.
A total of 1884 patients who were hospitalized at Fuwai Hospital for ISR and successfully treated with coronary intervention between January 2017 and December 2018 were included to determine whether there were myocardial infarction, recurrent ISR, TVR and other major adverse cardiovascular events (MACEs) within 4 years after intervention. The patients were divided into the MACE group (215 patients) and the non-MACE group (1669 patients). The clinical data of patients in the two groups were compared, and the risk factors for postoperative MACEs in the ISR patients were obtained by multivariate logistic regression analysis. The receiver operating characteristic (ROC) curve was used to determine the optimal prediction threshold for postoperative MACEs in ISR patients. The difference in survival curves between the two groups was compared using Kaplan‒Meier survival analysis.
The albumin (43.42 4.77 vs. 44.17 4.46, = 0.021), direct bilirubin (2.5 (2, 3.5) vs. 2.8 (2.07, 3.73), = 0.036) and free triiodothyronine (FT3) (2.85 0.43 vs. 2.92 0.42, = 0.019) levels in the MACE group were significantly lower than those in the non-MACE group, and there was a significant negative correlation between albumin and FT3 and MACEs. The results of univariate and multivariate logistic regression analyses revealed that FT3 was an independent predictor of postoperative MACEs in ISR patients (Odds Ratio (OR) = 0.626, 95% CI: 0.429-0.913, = 0.015). The ROC curve analysis determined that an FT3 value of 2.785 pmol/L was the optimal prediction threshold. According to the threshold, ISR patients were divided into the FT3 2.785 group and the FT3 2.785 group. The Kaplan‒Meier analysis revealed that the postoperative recurrence rate of MACEs of the FT3 2.785 group was substantially greater than that of the FT3 2.785 group (Hazard Ratio (HR) = 0.76, 95% CI: 0.58-0.994, = 0.044).
FT3 can be used as an independent predictor of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients. When FT3 is 2.785 pmol/L, the incidence of postoperative myocardial infarction, recurrent ISR and TVR in ISR patients increases significantly.
探讨冠状动脉支架内再狭窄(ISR)患者血管重建术后4年内发生心肌梗死、支架内再狭窄复发(ISR)及靶血管重建(TVR)的危险因素。
纳入2017年1月至2018年12月在阜外医院因ISR住院并成功接受冠状动脉介入治疗的1884例患者,确定干预后4年内是否发生心肌梗死、ISR复发、TVR及其他主要不良心血管事件(MACE)。将患者分为MACE组(215例)和非MACE组(1669例)。比较两组患者的临床资料,通过多因素logistic回归分析得出ISR患者术后发生MACE的危险因素。采用受试者工作特征(ROC)曲线确定ISR患者术后发生MACE的最佳预测阈值。采用Kaplan-Meier生存分析比较两组生存曲线的差异。
MACE组白蛋白(43.42±4.77 vs. 44.17±4.46,P = 0.021)、直接胆红素(2.5(2,3.5)vs. 2.8(2.07,3.73),P = 0.036)和游离三碘甲状腺原氨酸(FT3)(2.85±0.43 vs. 2.92±0.42,P = 0.019)水平显著低于非MACE组,且白蛋白、FT3与MACE之间存在显著负相关。单因素和多因素logistic回归分析结果显示,FT3是ISR患者术后发生MACE的独立预测因素(比值比(OR)=0.626,95%可信区间:0.429 - 0.913,P = 0.015)。ROC曲线分析确定FT3值为2.785 pmol/L是最佳预测阈值。根据该阈值,将ISR患者分为FT3≤2.785组和FT3>2.785组。Kaplan-Meier分析显示,FT3≤2.785组术后MACE复发率显著高于FT3>2.785组(风险比(HR)=0.76,95%可信区间:0.58 - 0.994,P = 0.044)。
FT3可作为ISR患者术后心肌梗死、ISR复发和TVR的独立预测因素。当FT3≤2.785 pmol/L时,ISR患者术后心肌梗死、ISR复发和TVR的发生率显著增加。